Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Asset Utilization Ratio (2020 - 2025)

Historic Asset Utilization Ratio for Fennec Pharmaceuticals (FENC) over the last 6 years, with Q3 2025 value amounting to 0.82.

  • Fennec Pharmaceuticals' Asset Utilization Ratio rose 193.93% to 0.82 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.82, marking a year-over-year increase of 193.93%. This contributed to the annual value of 1.32 for FY2024, which is 6759.56% up from last year.
  • As of Q3 2025, Fennec Pharmaceuticals' Asset Utilization Ratio stood at 0.82, which was up 193.93% from 0.73 recorded in Q2 2025.
  • Over the past 5 years, Fennec Pharmaceuticals' Asset Utilization Ratio peaked at 0.94 during Q1 2024, and registered a low of 0.04 during Q4 2022.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.37 (2023), whereas its average is 0.4.
  • As far as peak fluctuations go, Fennec Pharmaceuticals' Asset Utilization Ratio crashed by 35013.4% in 2022, and later skyrocketed by 438041.21% in 2023.
  • Over the past 5 years, Fennec Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.01 in 2021, then plummeted by 896.63% to 0.04 in 2022, then skyrocketed by 2366.74% to 0.91 in 2023, then grew by 0.88% to 0.92 in 2024, then decreased by 9.97% to 0.82 in 2025.
  • Its Asset Utilization Ratio was 0.82 in Q3 2025, compared to 0.73 in Q2 2025 and 0.68 in Q1 2025.